BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13955371)

  • 1. [Possibilities and limitations of additional control of malignant tumors by cytostatics, especially by podophyllin derivatives].
    HUBACHER O
    Radiol Clin; 1962; 31():194-204. PubMed ID: 13955371
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON CANCER THERAPY WITH PODOPHYLLIN DERIVATIVES. PRELIMINARY EXPERIENCES IN THE CYTOSTATIC TREATMENT OF MALIGNANT GENITAL TUMORS WITH SP-I AND SP-G SANDOZ].
    STAMM O
    Munch Med Wochenschr; 1964 Jan; 106():41-8. PubMed ID: 14133659
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIMENTAL RESULTS WITH THE PODOPHYLLUM-CYTOSTATICS SP-1 AND SP-G].
    STAEHELIN H; CERLETTI A
    Schweiz Med Wochenschr; 1964 Oct; 94():1490-502. PubMed ID: 14318344
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE CHEMISTRY OF THE NEW CYTOSTATICS SP-G AND SP-I].
    WEBER I; SCHILDT H
    Med Monatsschr; 1965 Jan; 19():10-3. PubMed ID: 14270687
    [No Abstract]   [Full Text] [Related]  

  • 5. [EFFECT OF THE LOCAL ENT APPLICATION OF CYTOSTATIC DRUGS SPG AND SPI].
    NEIGER N
    Pract Otorhinolaryngol (Basel); 1964; 26():269-72. PubMed ID: 14197499
    [No Abstract]   [Full Text] [Related]  

  • 6. [A CASE OF KAPOSI'S DISEASE TREATED WITH THE NEW CYTOSTATIC DRUGS SP-I AND SP-G].
    SIMONMERCHAN A; ALVAREZVIDAL F
    Actas Dermosifiliogr; 1964; 55():769-72. PubMed ID: 14309989
    [No Abstract]   [Full Text] [Related]  

  • 7. [DERIVATIVES OF PODOPHYLLOTOXIN IN CLINICAL ANTINEOPLASTIC USE. POSSIBILITIES OF USE IN THE TREATMENT OF GYNECOLOGIC NEOPLASMS].
    MAIJNELLI M
    Riv Ostet Ginecol; 1963 Jul; 18():410-5. PubMed ID: 14091710
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Lipozencić M; Padovan I
    Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
    [No Abstract]   [Full Text] [Related]  

  • 9. [A SUPPLEMENT TO CANCER OPERATIONS BY PODOPHYLLIN DERIVATIVES].
    ECKMANN L
    Schweiz Med Wochenschr; 1964 Nov; 94():1690-2. PubMed ID: 14337310
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE VALUE OF THE ADDITION OF A PODOPHYLLUM TOXIN COMPOUND TO THE SURGICAL AND RADIOLOGICAL TREATMENT OF MAMMARY CARCINOMAS].
    FRIDRICH R
    Radiol Clin; 1965; 34():142-6. PubMed ID: 14333394
    [No Abstract]   [Full Text] [Related]  

  • 11. [ATTEMPTED TREATMENT OF CANCER IN AN ADVANCED STAGE BY PODOPHYLLIN DERIVATIVES].
    MINET P; CHEVALIER P; DECHEVEZ C; DROCHMANS A; STRYCKMANS P; KENIS Y
    Brux Med; 1964 Oct; 44():1053-8. PubMed ID: 14207674
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE PODOPHYLLIN DERIVATIVES SP-I AND SP-G IN SUPPORTIVE THERAPY OF GENITAL BLASTOMAS. HISTOLOGIC EVALUATIONS].
    AQUILINI E
    Minerva Ginecol; 1964 Dec; 16():996-1001. PubMed ID: 14265272
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results in podophyllotoxin therapy of malignant tumors].
    SELIGER H
    Krebsarzt; 1955 Dec; 10(6):357-60. PubMed ID: 13287056
    [No Abstract]   [Full Text] [Related]  

  • 14. [Podophyllin treatment of bladder tumors].
    HVIDT V
    Nord Med; 1962 Dec; 68():1645-8. PubMed ID: 13955977
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON GENERAL AND LOCAL ANTIMITOTIC THERAPY OF GENITAL CARCINOMA WITH THE PODOPHYLLINIC DERIVATIVES SP-I AND SP-G].
    AQUILINI E
    Minerva Ginecol; 1964 Nov; 16():902-8. PubMed ID: 14231294
    [No Abstract]   [Full Text] [Related]  

  • 16. Some biochemical responses of normal and malignant tissues to tumor-necrotizing agents.
    WARAVDEKAR VS
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():297-305. PubMed ID: 13842853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of podophyllin and its derivatives on the growth of a transplanted tumor].
    NEUKOMM S; de TREY
    Oncologia; 1961; 14():219-23. PubMed ID: 14479189
    [No Abstract]   [Full Text] [Related]  

  • 18. [RESULTS OF OUR EXPERIENCE WITH SP-I AND SP-G IN THE TREATMENT OF MALIGNANT NEOPLASMS].
    MITI L; MASSEI V
    G Clin Med; 1963 Sep; 44():894-914. PubMed ID: 14315779
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE DISTRIBUTION OF THE ANTIMITOTIC AGENT, ETHYLHYDRAZIDE OF PODOPHYLLIC ACID (SP-I 77) IN THE BODY AND IN HUMAN MALIGNANT TUMORS].
    MEIER-RUGE W; KALBERER F; GRAUWILER J
    Klin Wochenschr; 1964 Oct; 42():1024-8. PubMed ID: 14332696
    [No Abstract]   [Full Text] [Related]  

  • 20. [NOTICE ON THE PREPARATION OF TETRAHYDROPYRANYL DERIVATIVES OF SOME PODOPHYLLUM LIGNANS].
    AUTERHOFF H; THEILACKER G
    Arch Pharm Ber Dtsch Pharm Ges; 1964 Sep; 297():546-9. PubMed ID: 14341918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.